v3.25.2
Common Stock and Preferred Stock (Tables)
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Summary of Warrants Outstanding

The following table summarizes information about shares issuable under warrants outstanding during the three and six months ended June 30, 2024 and for the period ended December 31, 2023:

 

   Warrant
shares
outstanding
   Weighted
average
exercise
price
   Weighted
average
remaining
life
   Intrinsic
value
 
Outstanding at January 1, 2023   682,563,502   $0.06    4.47    - 
Issued   551,515,432    -    -    - 
Exercised   (31,668,360)   0.05    -    - 
Expired or cancelled   -    -    -    - 
Outstanding and exercisable at December 31, 2023   1,202,410,574    0.06    3.18    - 
Issued   453,360,000    0.01    -    - 
Exercised   -    -    -    - 
Expired or cancelled   -    -    -    - 
Outstanding and exercisable at March 31, 2024   1,655,770,574    0.01    2.21    - 
Issued   391,384,296    0.00364    -    - 
Exercised   (3,346,420)   0.05    -    - 
Expired or cancelled   -    -    -    - 
Outstanding and exercisable at June 30, 2024   2,043,808,450   $0.01    2.64   $- 

 

(*) Of the 391,384,296 and 844,744,296 shares issued during the three and six months ended June 30, 2024 and 551,515,432 issued during the year ended December 31, 2023, respectively and 2,043,808,450 and 1,202,410,574 shares outstanding and exercisable at June 30, 2024 and December 31, 2023, respectively, the weighted average exercise price and weighted average remaining life was not included for 1,736,988,738 and 1,417,604,442 warrants, respectively because their amount and exercise price is variable. During the six months ended June 30, 2024, 226,800,000 warrants were issued as a result of the partial conversion of convertible debt and 617,944,296 warrants were issued are a result of an adjustment to the number of X, Y and Z warrants as a result of the terms of the agreement. See Note 5 for the exercise prices of Series X, Y, and Z warrants. Series X, Y, and Z warrants expire on September 11, 2025.